Treace Medical Concepts Inc (TMCI)
R&D to Revenue
9.54%
Fiscal year · Period ending:
TMCI R&D to Revenue
Latest reported9.54%period ending
Latest reported9.54%period ending
TMCI FY R&D/Revenue (12.86% → 9.54%)
Latest values, visible window
High-resolution chart · PNG
TMCI r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 9.5359% | |
| 9.8344% | |
| 8.2515% | |
| 9.5771% | |
| 10.8071% | |
| 10.1926% | |
| 12.8628% |